[Our Mental Health Crisis: RFK Jr. Faces Psychiatric Over-Prescribing](https://wbbsec.com/opinions-and-features/our-mental-health-crisis-rfk-jr-faces-psychiatric-over-prescribing-published-in-forbes/)
[Our Mental Health Crisis: RFK Jr. Faces Psychiatric Over-Prescribing](https://wbbsec.com/opinions-and-features/our-mental-health-crisis-rfk-jr-faces-psychiatric-over-prescribing-published-in-forbes/)

Press Releases

WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech Innovation

Posted in:Press Releases

WBB Securities President Dr. Steve Brozak moderated a panel at Biotech Showcase 2026 focused on ARPA-H and the role of federal investment in advancing biotech and healthcare innovation. The discussion featured senior ARPA-H leaders and explored how government and industry can work together to accelerate breakthrough science and real-world impact.

Read More about WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech Innovation
By:

WBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS

Posted in:Press Releases

WBB Securities today announced it had acted as the sole placement agent for a $9 million Series A funding round for FELIQS, a biotechnology company developing first-in-class small molecule therapeutics for rare pediatric retinal diseases. 

Read More about WBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS
By:

WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.

Posted in:Press Releases

WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled:
“Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.

Read More about WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.
By:

Dr. Steve Brozak, President of WBB Securities, will moderate a panel at the Biotech Showcase Conference on Wednesday, January 15, 2025, titled “The Need for Novel Responses to Disease Threats in a Fast-Changing World.”

Posted in:Press Releases

The Need for Novel Responses to Disease Threats in a Fast-Changing World.

Read More about Dr. Steve Brozak, President of WBB Securities, will moderate a panel at the Biotech Showcase Conference on Wednesday, January 15, 2025, titled “The Need for Novel Responses to Disease Threats in a Fast-Changing World.”
By:
Load More